登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 7414 条符合本次的查询结果， 用时 4.7718733 秒

1721. The role of physican associates under Labour reforms.

作者: Hamsa Aden.;Yahya Ali.
来源: Lancet. 2025年404卷10471期2542页

1722. Concerns about the role of physician associates in UK clinical practice.

作者: Ian Kunkler.
来源: Lancet. 2025年404卷10471期2541页

1723. Physician associates and patient safety.

作者: Matt Kneale.;Helen Fernandes.
来源: Lancet. 2025年404卷10471期2541-2542页

1724. Physician associates, competence expansion, and general practitioner burnout.

作者: Richard Armitage.
来源: Lancet. 2025年404卷10471期2540-2541页

1725. Xenotransplantation: the future is closer than we think.

作者: Pedro Antonio Cascales Campos.;Pablo Ramirez.
来源: Lancet. 2025年404卷10471期2539-2540页

1726. HIV and alcohol misuse among miners in Zimbabwe.

作者: Moira Majaha.;Chido Dziva Chikwari.;Samuel Kizito.;Dingani Moyo.;Fred Ssewamala.
来源: Lancet. 2025年404卷10471期2538页

1727. Combined liver-kidney transplantation: 40 years of saving lives.

作者: Xuyong Sun.;Xiaocong Kuang.;Ning Wen.;Zhiying Lei.;Liugen Lan.;Jihua Wu.;Ke Mo.;Xing Niu.
来源: Lancet. 2025年404卷10471期2538-2539页

1728. From bad to worse: the unbreathable air of Lahore.

作者: Sikandar Khan.
来源: Lancet. 2025年404卷10471期2537-2538页

1729. End non-consensual surgeries on intersex children in Serbia.

作者: Valentina Opancina.;Y Tony Yang.
来源: Lancet. 2025年404卷10471期2536-2537页

1730. Another claw hand in a Renaissance portrait.

作者: Alexis Demas.
来源: Lancet. 2025年404卷10471期2535页

1731. Top ten menopause research priorities.

作者: Zachary Nash.;Monica Christmas.;Toto Gronlund.;Martha Hickey.; .
来源: Lancet. 2025年404卷10471期2535-2536页

1732. European health security needs a reboot in 2025.

作者: The Lancet.
来源: Lancet. 2025年404卷10471期2487页

1733. The perils of RFK Junior's anti-vaccine leadership for public health.

作者: Y Tony Yang.
来源: Lancet. 2025年405卷10473期122页

1734. The first 100 days of the mpox response in Africa.

作者: Nicaise Ndembi.;Yap Boum.;Moréniké O Foláyan.
来源: Lancet. 2025年405卷10473期121-122页

1735. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.

作者: David T Rubin.;Jessica R Allegretti.;Julián Panés.;Nicole Shipitofsky.;Shadi S Yarandi.;Kuan-Hsiang Gary Huang.;Matthew Germinaro.;Rebbecca Wilson.;Hongyan Zhang.;Jewel Johanns.;Brian G Feagan.;Tadakazu Hisamatsu.;Gary R Lichtenstein.;Brian Bressler.;Laurent Peyrin-Biroulet.;Bruce E Sands.;Axel Dignass.; .
来源: Lancet. 2025年405卷10472期33-49页
Interleukin-23 inhibition is effective in treating ulcerative colitis. Guselkumab is a dual-acting, human IgG1, interleukin-23p19 subunit inhibitor that potently neutralises interleukin-23 and can bind to CD64. We aimed to evaluate the efficacy and safety of guselkumab as induction and maintenance therapy in patients with ulcerative colitis.

1736. Guselkumab in the IL-23 inhibition landscape for ulcerative colitis.

作者: Beatriz Gros.;Laura E Targownik.
来源: Lancet. 2025年405卷10472期2-3页

1737. Assisted dying, complex systems, and global equity in palliative care.

作者: Libby Sallnow.;Beatriz E Dorsey-Rivera.;Christian Ntizimira.;Nezamuddin Ahmad.;Suresh Kumar.
来源: Lancet. 2025年405卷10473期103-105页

1738. Making CAR T-cell therapies more affordable.

作者: Kathryn Senior.
来源: Lancet. 2025年405卷10474期187-188页

1739. What price is society willing to pay for new drugs?

作者: Victoria Charlton.
来源: Lancet. 2025年405卷10472期3-5页

1740. Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000-20: a retrospective analysis.

作者: Huseyin Naci.;Peter Murphy.;Beth Woods.;James Lomas.;Jinru Wei.;Irene Papanicolas.
来源: Lancet. 2025年405卷10472期50-60页
Health systems experience difficult trade-offs when paying for new drugs. In England, funding recommendations by the National Institute for Health and Care Excellence (NICE) for new drugs might generate health gains, but inevitably result in forgone health as the funds cannot be used for alternative treatments and services. We aimed to evaluate the population-health impact of NICE recommendations for new drugs during 2000-20.
共有 7414 条符合本次的查询结果， 用时 4.7718733 秒